According to Roche's latest financial reports the company's current EPS (TTM) is 15,38 โฌ. In 2022 the company made an earnings per share (EPS) of 15,38 โฌ a decrease over its 2021 EPS that were of 16,42 โฌ.
Year | EPS | Change |
---|---|---|
2022 | 15,38 โฌ | -6.29% |
2021 | 16,42 โฌ | -5.53% |
2020 | 17,38 โฌ | 16.56% |
2019 | 14,91 โฌ | 30.3% |
2018 | 11,44 โฌ | 20.22% |
2017 | 9,52 โฌ | -5.81% |
2016 | 10,10 โฌ | 4.62% |
2015 | 9,66 โฌ | -5.13% |
2014 | 10,18 โฌ | -25.05% |
2013 | 13,58 โฌ | 21.73% |
2012 | 11,16 โฌ | 3.82% |
2011 | 10,75 โฌ | 8.16% |
2010 | 9,94 โฌ | 23.72% |
2009 | 8,03 โฌ | -12.31% |
2008 | 9,16 โฌ | -0.34% |
2007 | 9,19 โฌ | 32.13% |
2006 | 6,95 โฌ | 42.56% |
2005 | 4,88 โฌ | -22.7% |
2004 | 6,31 โฌ | 132.85% |
2003 | 2,71 โฌ | -154.73% |
2002 | -4,95 โฌ | -209.09% |
2001 | 4,54 โฌ | -57.25% |
2000 | 10,62 โฌ | 67.41% |
1999 | 6,34 โฌ | 31.24% |
1998 | 4,83 โฌ |